Plain-English translation of NCT03772275 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are looking for new blood markers—measurable signs in your blood—that could help doctors better understand and manage chronic heart failure. This diagnostic study will compare blood markers in patients with different levels of heart failure severity to see if these new markers can provide useful information for treatment and care decisions.
Currently, doctors rely on standard tests to diagnose and monitor heart failure, but these tests don't always capture the full picture of what's happening in a patient's body. This research aims to find new blood markers that could give doctors earlier warning signs and help them better understand each patient's condition.
You likely qualify if…
You likely don't qualify if…
You will be asked to donate blood samples and complete clinical evaluations so researchers can measure the new biomarkers and compare them across different heart failure severity groups. The study will help determine whether these new blood markers are useful for diagnosing and managing heart failure in everyday clinical care.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Egypt